IDNNA, also known as 4-iodo-2,5-dimethoxy-N,N-dimethylamphetamine or as N,N-dimethyl-DOI, is a chemical compound of the phenethylamine, amphetamine, and DOx families. It is the N,N-dimethyl derivative of the psychedelic drug DOI.
Use and effects In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists IDNNA's dose as greater than 2.6 mg orally and its duration as unknown. IDNNA produced no effects at tested doses. Higher doses were not assessed.
Chemistry
Synthesis The chemical synthesis of IDNNA has been described.
Analogues Analogues of IDNNA include DOI, N-methyl-DOI, methyl-DOB (N-methyl-DOB), Beatrice (N-methyl-DOM), N-methyl-DOET, N-methyl-2C-I, and N-methyl-2C-B, among others.
History IDNNA was first described in the scientific literature by Alexander Shulgin and colleagues in 1982. Subsequently, it was described in greater detail by Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.
Society and culture
Legal status
Canada IDNNA is a controlled substance in Canada under phenethylamine blanket-ban language.
United Kingdom This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
See also DOx (psychedelics)
References
External links IDNNA - Isomer Design IDNNA - PiHKAL - Erowid IDNNA - PiHKAL - Isomer Design


